Real World Effectiveness and Tolerability of low-dose opiates for Refractory/Unexplained Chronic Cough (RCC/UCC) in a tertiary clinic
J. King (Manchester (Greater Manchester), United Kingdom), J. Wingfield-Digby (Manchester (Greater Manchester), United Kingdom), S. Hennessey (Manchester (Greater Manchester), United Kingdom), A. Woodcock (Manchester (Greater Manchester), United Kingdom), J. Smith (Manchester (Greater Manchester), United Kingdom), P. Marsden (Manchester (Greater Manchester), United Kingdom), J. Wingfield Digby (Manchester (Greater Manchester), United Kingdom)
Source: International Congress 2022 – Chronic cough, airway diseases and methods
Session: Chronic cough, airway diseases and methods
Session type: Thematic Poster
Number: 175
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. King (Manchester (Greater Manchester), United Kingdom), J. Wingfield-Digby (Manchester (Greater Manchester), United Kingdom), S. Hennessey (Manchester (Greater Manchester), United Kingdom), A. Woodcock (Manchester (Greater Manchester), United Kingdom), J. Smith (Manchester (Greater Manchester), United Kingdom), P. Marsden (Manchester (Greater Manchester), United Kingdom), J. Wingfield Digby (Manchester (Greater Manchester), United Kingdom). Real World Effectiveness and Tolerability of low-dose opiates for Refractory/Unexplained Chronic Cough (RCC/UCC) in a tertiary clinic. 175
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|